Induced sputum is safe and well-tolerated for TB diagnosis in a resource-poor primary healthcare setting. by Ugarte-Gil, Cesar et al.
Ugarte-Gil, Cesar; Elkington, Paul T; Gotuzzo, Eduardo; Friedland,
Jon S; Moore, David AJ (2015) Induced Sputum Is Safe and Well-
Tolerated for TB Diagnosis in a Resource-Poor Primary Healthcare
Setting. AMERICAN JOURNAL OF TROPICAL MEDICINE AND
HYGIENE, 92 (3). pp. 633-635. ISSN 0002-9637 DOI: https://doi.org/10.4269/ajtmh.14-
0583
Downloaded from: http://researchonline.lshtm.ac.uk/4652598/
DOI: 10.4269/ajtmh.14-0583
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Am. J. Trop. Med. Hyg., 92(3), 2015, pp. 633–635
doi:10.4269/ajtmh.14-0583
Copyright © 2015 by The American Society of Tropical Medicine and Hygiene
Induced Sputum Is Safe and Well-Tolerated for TB Diagnosis
in a Resource-Poor Primary Healthcare Setting
Cesar Ugarte-Gil,* Paul T. Elkington, Eduardo Gotuzzo, Jon S. Friedland, and David A. J. Moore
Instituto de Medicina Tropical Alexander Von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru´; Department of Infectious
Diseases and Immunity, Imperial College London, London, United Kingdom; Clinical and Experimental Sciences, University of Southampton,
Southampton, United Kingdom; Laboratorios de Investigacio´n y Desarrollo, Universidad Peruana Cayetano Heredia, Lima, Peru´;
London School of Hygiene and Tropical Medicine Tuberculosis Centre and Department of Clinical Research,
London School of Hygiene and Tropical Medicine, London, United Kingdom
Abstract. Improved tuberculosis (TB) diagnostics are required. Induced sputum sampling is superior to spontaneous
sputum analysis for diagnosis of pulmonary TB. Therefore, we examined the applicability of induced sputum in primary
health centers of the Peruvian TB program and studied the safety and tolerability of this procedure. We show that
induced sputum is safe, inexpensive, and well-tolerated in a resource-limited environment. Widespread use of induced
sputum at primary health centers can be implemented and may improve TB diagnosis.
INTRODUCTION
Tuberculosis (TB) remains a major diagnostic challenge in
resource-poor settings, despite the global effort in developing
new diagnostic tests and biomarkers. Failure to diagnose pul-
monary TB early in the course of infection results in progres-
sive lung disease, cavitation, and ongoing transmission of
infection, because patients with pulmonary cavities are highly
infectious. A fundamental problem is the low sensitivity of
spontaneous sputum smear for acid-fast bacilli (AFB) to diag-
nose pulmonary TB.1 One central reason for this is the highly
variable quality of sputum samples: in many cases, patients
need to produce two or three samples for diagnosis.2
The induced sputum procedure is a well-established tech-
nique3 to obtain consistent samples from the respiratory tract.4
Studies in TB have shown its efficacy in improving diagnosis,
especially in children and human immunodeficiency virus
(HIV) -positive patients.4 However, the use of induced sputum
is primarily restricted to tertiary-level health centers. The
potential of induced sputum as a method to obtain improved
sputum samples for research purposes in primary healthcare
settings, where the majority of TB patients access care, has
recently been shown.5–7 Therefore, we studied the tolerability
of induced sputum for diagnosis of TB in a resource-poor pri-
mary healthcare setting and show that induced sputum is safe
and well-tolerated in patients with TB.
METHODS
Participants were recruited for a cross-sectional and cohort
study among patients presenting with symptoms suggestive of
pulmonary TB. The inclusion and exclusion criteria have been
described previously.8 Sixty-eight adult TB patients were
recruited prospectively at the time of diagnosis with a smear
and/or culture positive forMycobacterium tuberculosis. Sixty-
nine healthy controls were recruited in the same setting as TB
patients, and they had sputum smears and cultures negative
forM. tuberculosis.
To study the safety of the procedure, a research nurse
recorded theO2 saturationwith anNBP-40 saturometer (Nellcor
Puritan Bennet, Galway, Connacht, Ireland), blood pressure (at
the beginning and the end of the procedure), and any adverse
events that occurred. We considered O2 saturation below 92%
as hypoxemia.9
Induced sputum was performed with a portable compressor
nebulizer NA180 (Aspen, Buenos Aires, Argentina) with a dis-
posable mask in a specially designed room at the Tuberculosis
Clinic without a roof, with direct sunlight, and good air
flow for good ventilation. The nebulizer cost is $90, and dispos-
ables were $4 for each patient (saline, mask, and disposable
tubing). The procedure took a total of 30 minutes and required
10 mL 3% saline (Farmacia Universal, Lima, Peru) using a
similar protocol described before.8,10 The analysis was done
with Stata 12 (StataCorp, College Station, TX). This study was
approved by the Ethics Committee of the Universidad Peruana
Cayetano Heredia.
RESULTS AND DISCUSSION
There were 137 participants: 69 (50.4%) healthy controls
and 68 (49.6%) TB patients. The characteristics of the popula-
tion and sputum samples are shown in Table 1. The procedure
was well-tolerated. Among healthy controls, only dizziness was
reported as an adverse event in two (3%) participants. Among
TB patients, minor events reported were nausea, headache,
tachycardia, and dyspnea (three participants for each adverse
event; 4.4%): one participant reported experiencing all four
of these adverse events, one participant reported two events
(tachycardia and dyspnea), and six participants reported only
one event. All participants completed the procedure without
any serious complications. MeanO2 saturation at the beginning
and the end of the procedure was similar and within safe
ranges, and there was no difference between TB patients
and healthy controls (Table 1). All symptoms were mild, and
no additional interventions beyond reassurance and comfort
measures were required. All symptoms disappeared within
20 minutes of the procedure. There were no associations
between TB status, body mass index (BMI), and age at enroll-
ment with the likelihood of experiencing an adverse event.
Induced sputum has previously been shown to be a safe
procedure in the case of asthmatic patients, with good tolera-
bility and minimum clinical risks.11 Also, this procedure
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showed an increased sensitivity for TB diagnosis in patients
with problems producing spontaneous sputum samples (such
as HIV-positive patients and children).12 Similar to our study,
good tolerance of the induced sputum procedure was seen
among adults and adolescents with suspected TB (HIV-positive
and -negative) in a community healthcare setting in South
Africa.6 We did not perform a pre-nebulization step and still
found no significant adverse events, showing that induction
directly with hypertonic saline can be undertaken safely. Addi-
tionally, we reveal no difference in the likelihood of adverse
events between healthy controls and TB patients.
Improved diagnostic tests for pulmonary TB are urgently
required. Sputum induction is relatively easy to perform at
the primary health level and well-tolerated in open-air condi-
tions. Some studies refer to a potential risk for nosocomial
transmission13,14; however, the design of the room (with open
air and direct sunlight) reduces this potential risk. Adequate
natural ventilation showed efficiency in nosocomial settings,15
and in addition to adequate biosafety training, protection
measures for the personnel (i.e., N95 masks) should be the
norm in all sputum procedures (induced sputum, smear, and
culture procedures) The sensitivity, tolerability, and low cost
of induced sputum make it a powerful tool in low-resource
settings to improve the quality of sputum samples. The advan-
tages of induced sputum are the simplicity of the technique
and its use for both diagnostics and research; in our study, we
used an inexpensive but robust electrical machine, which can
be used in resource-poor settings. The cost of $4 for the kit
per patient can be cost-effective, considering that the delay in
diagnosis increases the risk of medical complications and
transmission with the consequent increases in the costs for
the patient and the health system.
This study has some limitations. We did not measure forced
expiratory volume (FEV) to assess potential airway constric-
tion, but it is difficult to measure FEV in this setting because
of concerns relating to infection control (disposable materials,
etc.), which is not normally available in low-income settings.
Considering that, in both studies in resource-poor settings,
none of the participants had severe adverse events after the
procedure, we can assume that induced sputum poses minimal
risk for airway constriction. Nevertheless, we suggest first eval-
uating the risk for airway constriction (low O2 saturation, pre-
vious history of asthma attacks, or other conditions for airway
constriction) and second, having an emergency kit, including
salbutamol for nebulization, available (which should be avail-
able in any healthcare center) to reduce this potential risk.
One limitation of induced sputum for routine diagnosis is
that, on average, the procedure takes 30 minutes. In a setting
with a high flow of patients, this would be problematic, and
therefore, induced sputum should be reserved for diagnostic
challenges, such as children and patients with non-productive
cough, like in early pulmonary TB. However, its simplicity
makes this procedure a viable solution in settings where there
is a shortage of doctors, and it can be performed by nurses and
health technicians.
In conclusion, induced sputum is a safe procedure in pri-
mary healthcare settings and can be deployed to improve the
quality of sputum for diagnosis or research purposes. For non-
productive respiratory symptomatic or HIV-positive patients,
wider use of induced sputum may greatly increase TB diag-
nostic yield without risk of adverse events.
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